David L. Rosen, a partner and co-chair of the Life Sciences Industry Team of Foley & Lardner LLP will participate in presenting the Webcast, “Introduction to Drug and Medical Device Law” hosted by the The Regulatory Affairs Professionals Society. This course will provide an overview of how drugs and medical devices are regulated in the United States. Attendees will specifically:
- Learn the basics concerning the laws and regulations that impact the pharmaceutical industry
- Gain an understanding of the different statutory provisions and how they operate in reality
- Get a sense of FDA’s organization, the history of drug regulation, and how new drugs, generic drugs and over-the-counter (OTC) drugs get into the marketplace
- Learn the basics concerning the laws and regulations that impact the medical device industry
- Get a sense of FDA’s organization, the history of medical device regulation and how new medical devices and substantially equivalent medical devices get in the market place and the post market requirements
- Gain an overview of the Quality System Regulation (QSR), adverse events, and promotion and advertising
People
Related Insights
August 13, 2025
Foley Viewpoints
DOJ Issues Additional Guidance Concerning Unlawful Discrimination to Recipients of Federal Funding
On July 29, 2025, the DOJ issued guidance clarifying that federal antidiscrimination laws apply to all federally funded programs, including DEI initiatives.
August 13, 2025
Tariff & International Trade Resource
Five Compliance Best Practices for … Customs Intellectual Property Rights
Discover five key compliance best practices for protecting intellectual property through U.S. Customs. Learn how importers can register IP, collaborate with CBP, and proactively prevent counterfeit goods from entering the supply chain.
August 13, 2025
Tariff & International Trade Resource
What Every Multinational Should Know About … the Use of Reshoring to Navigate Tariff Uncertainty
Learn how reshoring helps manufacturers manage tariff risk, improve supply chain resilience, and adapt to volatile trade policies in 2025.